Mind & Emotions · ScienceDaily Chronic Illness · October 23, 2026

Breakthrough PTSD treatment achieves 68% remission rate in clinical trial

A newly FDA-cleared PTSD treatment uses personalized brain mapping and magnetic stimulation to target abnormal brain activity, with a clinical trial reporting a 52% reduction in symptoms and 68% remission. Researchers believe the technology could transform PTSD care and pave the way for more precise treatments for other mental health conditions.

Originally published by ScienceDaily Chronic Illness. We curate and add context; they did the reporting.

Read the full story at ScienceDaily Chronic Illness ↗

Related learning

Living Alone Linked to Mortality Risk From Multiple Causes in U.S. Including Cancer; Suicide Highest How Psychological Flexibility Can Help Us Belong The brain’s hidden fear mechanism may explain anxiety and PTSD The brain’s hidden fear mechanism may explain anxiety and PTSD